Targeted therapies in neuroendocrine neoplasms
Journal Title: OncoReview - Year 2012, Vol 2, Issue 3
Abstract
The primary treatment of gastrointestinal neuroendocrine tumors is surgery, and its extent depends on the clinical stage of cancer. In advanced disease medical therapy is used. One possible form of treatment is biological therapy and radionuclide therapy (PRRT, peptide receptor radionuclide therapy) using radiolabeled somatostatin analogues. The effects of these treatments can improve the combinations of radioactive labeled somatostatin analogues, intra-arterial administered, and the use of radio sensitizing drugs combined with PRRT or PRRT combined with new targeted therapeutic agents such as sunitinib or everolimus. New targeted agents (angiogenesis inhibitors, single and multiple tyrosine kinase inhibitors and new somatostatin analogues, such as pasyreotyd) also evaluated in II and III phase clinical trials. Currently, there are several studies on the efficacy of a combination of different, present and new treatments. PRRT with the combination of sunitinib or everolimus or sequential use of PRRT and one of these compounds may be a promising solution for the treatment of patients with pancreatic endocrine tumors.
Authors and Affiliations
Violetta Rosiek, Beata Kos-Kudła
Keywords
Related Articles
- EP ID EP53164
- DOI -
- Views 246
- Downloads 0
Bezpieczeństwo kardiologiczne podczas stosowania sunitinibu i sorafenibu, wielokinazowych inhibitorów angiogenezy
Kardiotoksyczność wielokinazowych inhibitorów angiogenezy, sunitinibu i sorafenibu, objawia się najczęściej w postaci dysfunkcji skurczowej mięśnia sercowego oraz tętniczych i żylnych zdarzeń zakrzepowo-zatorowych. Istot...
Consensus statement on indications for the use of non-pegylated liposomal doxorubicin in patients with lymphomas and concomitant cardivascular diseases
Nowe spojrzenie na ocenę skuteczności terapii celowanych zaawansowanego raka nerki– kontrowersje
W ciągu ostatnich kilku lat daje się zaobserwować zdecydowany rozwój nowoczesnych terapii stosowanych w leczeniu zaawansowanego/ rozsianego raka nerki, związany przede wszystkim z poznaniem podstaw molekularnych raka ner...
Imaging for Cardiotoxicity: Many Issues, Many Questions
Dermatofibrosarcoma protuberans (DFSP) – advances in diagnostics and therapy
Dermatofibrosarcoma protuberans is a rare soft tissue sarcoma with a superficial growth. It has an estimated incidence of 4 cases per one million persons per year. DFSP is preferentially located on the trunk. It can appe...